DE68928527D1 - Albumin enthaltende Zusammensetzung und Verfahren zu ihrer Herstellung - Google Patents

Albumin enthaltende Zusammensetzung und Verfahren zu ihrer Herstellung

Info

Publication number
DE68928527D1
DE68928527D1 DE68928527T DE68928527T DE68928527D1 DE 68928527 D1 DE68928527 D1 DE 68928527D1 DE 68928527 T DE68928527 T DE 68928527T DE 68928527 T DE68928527 T DE 68928527T DE 68928527 D1 DE68928527 D1 DE 68928527D1
Authority
DE
Germany
Prior art keywords
preparation
composition containing
containing albumin
albumin
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68928527T
Other languages
English (en)
Other versions
DE68928527T2 (de
Inventor
Yasushi Matsuoka
Shinichirou Hase
Kazuo Takechi
Shinji Tomioka
Kazumasa Yokoyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26451019&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE68928527(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Application granted granted Critical
Publication of DE68928527D1 publication Critical patent/DE68928527D1/de
Publication of DE68928527T2 publication Critical patent/DE68928527T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE68928527T 1988-10-31 1989-10-31 Albumin enthaltende Zusammensetzung und Verfahren zu ihrer Herstellung Expired - Fee Related DE68928527T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27708288 1988-10-31
JP11168189A JP3554796B2 (ja) 1988-10-31 1989-04-28 アルブミン製剤及びその製造方法

Publications (2)

Publication Number Publication Date
DE68928527D1 true DE68928527D1 (de) 1998-02-12
DE68928527T2 DE68928527T2 (de) 1998-05-28

Family

ID=26451019

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68928527T Expired - Fee Related DE68928527T2 (de) 1988-10-31 1989-10-31 Albumin enthaltende Zusammensetzung und Verfahren zu ihrer Herstellung

Country Status (7)

Country Link
EP (1) EP0367220B1 (de)
JP (1) JP3554796B2 (de)
KR (1) KR100201195B1 (de)
AU (1) AU624436B2 (de)
CA (1) CA2001911A1 (de)
DE (1) DE68928527T2 (de)
ES (1) ES2110947T3 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0768137B2 (ja) * 1989-06-15 1995-07-26 株式会社ミドリ十字 アルブミン製剤及びその製法
US5250662A (en) * 1989-10-05 1993-10-05 Alpha Therapeutic Corporation Albumin purification
CA2022165C (en) * 1989-10-05 1999-11-23 Chong E. Chang Albumin purification
JP2949846B2 (ja) * 1990-11-30 1999-09-20 吉富製薬株式会社 アルブミン製剤の保存方法
FR2672604B1 (fr) * 1991-02-07 1995-05-05 Pasteur Merieux Serums Vacc Procede pour isoler de l'albumine humaine a partir du surnageant iv, notamment iv-4, ou de la fraction v de cohn ou d'un surnageant ou fraction analogue.
FR2690444B1 (fr) * 1992-04-22 1995-07-13 Rucheton Marcel Procede de preparation d'une solution d'albumine plasmatique purifiee.
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
JPH07102148B2 (ja) * 1992-05-20 1995-11-08 株式会社ミドリ十字 遺伝子操作により得られるヒト血清アルブミンの製造方法、およびそれにより得られるヒト血清アルブミン含有組成物
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
JPH07126182A (ja) * 1993-10-27 1995-05-16 Green Cross Corp:The 組換えヒト血清アルブミン製剤の滅菌方法
AUPM388494A0 (en) * 1994-02-16 1994-03-10 Csl Limited Process for removing endotoxins
JP3702474B2 (ja) * 1994-06-01 2005-10-05 三菱ウェルファーマ株式会社 血清アルブミン製剤の製造方法
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
JP4798832B2 (ja) * 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 ヒト血清アルブミン多量体の除去方法
US7252799B2 (en) 2001-08-31 2007-08-07 Clearant, Inc. Methods for sterilizing preparations containing albumin
RS20050401A (en) * 2002-11-25 2007-06-04 Octapharma Ag., Prekallikrein depleted plasma derived albumin fraction
ES2543978T3 (es) * 2003-04-09 2015-08-26 The Chemo-Sero-Therapeutic Research Institute Proceso para la producción de una preparación de albúmina
GB0423196D0 (en) 2004-10-19 2004-11-24 Nat Blood Authority Method
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2537123A1 (de) * 1975-08-20 1977-03-03 New Zealand Inventions Dev Verfahren zur herstellung von albumin
SE405549B (sv) * 1975-10-09 1978-12-18 Pharmacia Fine Chemicals Ab Forfarande for isolering av albumin ur plasmaprodukter genom kromatografisk fraktionering
US4043997A (en) * 1976-05-28 1977-08-23 Cutter Laboratories, Inc. Method for isolating albumin using insoluble supports coupled to a dye
US4075197A (en) * 1976-09-20 1978-02-21 Monsanto Company Serum albumin production
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
FR2543448A1 (fr) * 1983-04-01 1984-10-05 Rhone Poulenc Spec Chim Procede de fractionnement du plasma
DE3344656A1 (de) * 1983-12-09 1985-06-13 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung einer serumproteinloesung

Also Published As

Publication number Publication date
AU4394389A (en) 1990-05-03
AU624436B2 (en) 1992-06-11
KR900005987A (ko) 1990-05-07
DE68928527T2 (de) 1998-05-28
EP0367220B1 (de) 1998-01-07
KR100201195B1 (ko) 1999-06-15
EP0367220A3 (de) 1991-10-09
ES2110947T3 (es) 1998-03-01
CA2001911A1 (en) 1990-04-30
JP3554796B2 (ja) 2004-08-18
JPH02191226A (ja) 1990-07-27
EP0367220A2 (de) 1990-05-09

Similar Documents

Publication Publication Date Title
DE68928527D1 (de) Albumin enthaltende Zusammensetzung und Verfahren zu ihrer Herstellung
ATA125988A (de) Pharmazeutische cefuroximaxetil-zusammensetzung und verfahren zu ihrer herstellung
DE68910654D1 (de) Beschichtungszusammensetzung und Verfahren zu ihrer Herstellung.
DE68912983T3 (de) Waschmittelzusammensetzungen und Verfahren zu deren Herstellung.
DE69229826D1 (de) Tensidzusammensetzung und Verfahren zu ihrer Herstellung
DE69126339D1 (de) Perfluorether und Verfahren zu ihrer Herstellung
DE69411604D1 (de) Wirkstoffzusammensetzung und Verfahren zu ihrer Herstellung
DE68926866D1 (de) Detergentspulver und Verfahren zu ihrer Zubereitung
DE3789243D1 (de) Naphthalocyaninverbindungen und Verfahren zu ihrer Herstellung.
DE69224861T2 (de) Neue Phenylacetamidderivate und Verfahren zu ihrer Herstellung
PT85302A (de) 7-acyloxy-6-aminoacyloxypolyxylabdane verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3886377D1 (de) Blockcopolymerzusammensetzungen und Verfahren zu deren Herstellung.
PT86826A (pt) Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
DE69305256D1 (de) Wässrige Dispersionszusammensetzung und Verfahren zu ihrer Herstellung
DE68923993D1 (de) Polymaleimid-Verbindungen und Verfahren zu ihrer Herstellung.
DE69106627D1 (de) Oligohexafluorpropylenverbindungen und Verfahren zu ihrer Herstellung.
DE69114420D1 (de) Organozyklosiloxane und Verfahren zu ihrer Herstellung.
PT78487B (de) 4-phenyl-tetrahydro-furano-pyridine verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
DE3856473D1 (de) Supraleitende Werkstoffe und Verfahren zu ihrer Herstellung
DE69012655D1 (de) Alpha-(omega-cyanoalkanoyl)-gamma-butyrolactone und Verfahren zu ihrer Herstellung.
DE69017091D1 (de) Cyclomalto-oligosaccharidderivate und Verfahren zu ihrer Herstellung.
DE59206999D1 (de) Oxadimethacryl-Verbindungen und Verfahren zu ihrer Herstellung
DE69010086D1 (de) Organosiliciumverbindungen und Verfahren zu ihrer Herstellung.
DE68914500D1 (de) Alkylarylsulfone und Verfahren zu ihrer Herstellung.
PT81078B (de) Aminosaeurederivate verfahren zu ihrer herstellung und pharmazeutische zusamensetzungen

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD., OSAKA,

8327 Change in the person/name/address of the patent owner

Owner name: WELFIDE CORP., OSAKA, JP

8327 Change in the person/name/address of the patent owner

Owner name: MITSUBISHI PHARMA CORP., OSAKA, JP

8339 Ceased/non-payment of the annual fee